Completed trials

An Open-Label, Randomised Phase 1b/2 Study Of PF-04691502 In Combination With Letrozole Compared With Letrozole Alone In Patients With Estrogen Receptor Positive, Her-2 Negative Early Breast Cancer

Cancer type: Breast cancer

Phase: I/II

Principal Investigator: Bergh Jonas

Country: SE

Keywords: Sweden, Breast Cancer, HER-2 positive, Estrogen receptor positive, PF-04691502, letrozole

Status: Completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01430585?term=PF-04691502&rank=3